Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

EyeGate Pharmaceuticals Inc buy Quitte

EyeGate Pharmaceuticals Inc
Start price
€24.62
30.01.17 / 50%
Target price
€2.44
22.02.17
Performance (%)
49.99%
End price
€36.94
22.02.17
Summary
This prediction ended on 22.02.17 with a price of €36.94. The BUY prediction by Quitte for EyeGate Pharmaceuticals Inc saw massive gains of 49.99%. Quitte has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
EyeGate Pharmaceuticals Inc - - - -
iShares Core DAX® -1,74 % 5,98 % 8,98 % 49,86 %
iShares Nasdaq 100 2,81 % 11,83 % 38,41 % 100,33 %
iShares Nikkei 225® -0,11 % 11,69 % 46,68 % 65,35 %
iShares S&P 500 0,97 % 7,62 % 28,14 % 68,66 %

Comments by Quitte for this prediction

In the thread EyeGate Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 49.99%
Target price 2.435
Change
Ends at 22.02.17

was auf die Augen

ein Versuch ist es wert


http://crweworld.com/article/press-releases/56356/eyegate-pharma-announces-positive-top-line-data-from-first-in-human-pilot-trial-of-ocular-bandage-gel-in-corneal-epithelial-defects

Quitte 
0
Report Share
30.01.17
Prediction Buy
Perf. (%) 49.99%
Target price 2.435
Change
Ends at 22.02.17

(Zielkurs erreicht)

Quitte 
0
Report Share
22.02.17